AnBogen Therapeutics Revenue and Competitors
Employee Data
- AnBogen Therapeutics has 18 Employees.
- AnBogen Therapeutics grew their employee count by 20% last year.
AnBogen Therapeutics's People
Name | Title | Email/Phone |
---|
AnBogen Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 18 | 20% | N/A | N/A |
What Is AnBogen Therapeutics?
Anbogen Therapeutics is a clinical stage precision oncology company dedicated in developing first/best-in-class personalized therapeutics and making difference in patients' life. We bridge the gap between discovery candidates and proof-of-concept indications to challenge the unmet needs.\n\nHeadquartered in Taiwan, we are advancing a pipeline of precision medicines for the treatment of solid tumors. Currently with three assets including ABT-101 and ABT-301 under clinical development.
keywords:N/AN/A
Total Funding
18
Number of Employees
N/A
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.7M | 19 | -34% | N/A |
#2 | $2M | 20 | N/A | N/A |
#3 | $2M | 20 | -5% | N/A |
#4 | $3.3M | 21 | -9% | N/A |
#5 | $3.6M | 25 | 19% | N/A |